2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow q-griffithsin: new trials by email Literature Review of q-griffithsin trials Research Report on q-griffithsin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis Q-Griffithsin, Placebo - COVID-19, Pharmacokinetics | Phase 1 | Completed | Sharon Hillier | 50 | 2022-03-15 | 2024-04-23 |
| PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray Q-Griffithsin, Placebo - COVID-19 Prevention | Phase 1 | Completed | Kenneth Palmer | 18 | 2021-11-11 | 2022-04-29 |
| Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT) Q-Griffithsin (Q-GRFT) enema, Placebo enema - HIV Prevention | Phase 1 | Terminated | Rhonda Brand | 18 | 2019-07-10 | 2023-07-06 |
COVID-19 (2) · Coronavirus Infections (1)
Kenneth Palmer (1) · Rhonda Brand (1) · Sharon Hillier (1)
United States (3)
Ken Ho, MD (1) · Sharon L Hillier, PhD (1)
P30CA047904 (1), U19AI113182 (1)